GlassScriptPhysician profile
Logan Blankenship
NPI 1871955633
$1,602.85
in general payments reported to CMS, 2019-2025
20 companies · $723 in 2025
The $723 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $339 · 2023: $45.66 · 2024: $496 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,263.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $215.33 | 2022-2025 | Jemperli, Zejula |
| Abbvie INC. | $176.09 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $148.88 | 2024-2025 | Lynparza, Keytruda |
| Seagen INC. | $142.37 | 2022 | |
| Daiichi Sankyo INC. | $141.81 | 2024-2025 | Datroway, Enhertu, Injectafer |
| Eisai INC. | $134.46 | 2022-2025 | |
| Kci USA, INC. | $131.46 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $128.61 | 2024-2025 | Lynparza |
| Caris Mpi, INC. | $85.46 | 2025 | Mi Cancer Seek |
| Myriad Genetic Laboratories, INC. | $57.86 | 2024-2025 | Precisetumor |
| Fennec Pharmaceuticals, INC. | $43.44 | 2024 | Pedmark |
| Pfizer INC. | $37.27 | 2025 | |
| Smith+Nephew, INC. | $27.31 | 2024 | Grafix Pl |
| Integra Lifesciences Corporation | $23.67 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Novartis Pharmaceuticals Corporation | $22.58 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunogen, INC. | $22.10 | 2023 | Elahere |
| Solventum Corporation | $17.77 | 2024 | Prevena |
| Meditrina | $16.40 | 2025 | |
| Stryker Corporation | $15.63 | 2022 | |
| Guard Medical INC. | $14.35 | 2024 | Npseal Large |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Blankenship listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.